Advertisement

The Development of the False Neurotransmitter Concept of Hepatic Encephalopathy

  • J. E. Fischer

Abstract

The concept of weak, or false, neurochemical transmitters arose in the early 60’s to describe a series of potential neurotransmitters which were similar in structure to true aminergic neurotransmitters, norepinephrine and epinephrine, and which, when tested pharmacologically, manifested weak, or in some cases, almost absent Pharmacological action.l According to this concept, the sympathetic nerve or, by extension, the central nervous system, is unable to select between amines presented to it, that is unable to detect or choose between various aminergic neurotransmitters, provided they meet minimum structural requirements. In the case of the catecholamine and aminergic nerves, these structural requirements include a phenolic ring and a beta hydroxy group on a short carboxyl side change. It is curious that the normal adrenergic nervous system is incapable of distinguishing between these various potential neurotransmitters and that the maintenance of normal neurotransmitter profiles within the peripheral sympathetic nerve or the central nervous system is apparently dependent on the regulating ability of the liver to regulate different metabolites, including the precursors of these various adrenergic transmitters, namely the aromatic and heterocyclic amino acids.

Keywords

Hepatic Encephalopathy Aromatic Amino Acid Neutral Amino Acid Plasma Amino Acid Hepatic Coma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J. E. Fischer and R. J. Baldessarini, False neurotransmitters and hepatic failure, Lancet ii: 75 (1981).Google Scholar
  2. 2.
    K. Dismukes, A new look at the aminergic nervous system, Nature 269: 557 (1977).CrossRefGoogle Scholar
  3. 3.
    M. L. Mashford, W. A. Mahon, and T. C. Chalmers, Studies of the cardiovascular system in the hypotension of liver failure, N. Engl. J. Med. 267: 1071 (1962).PubMedCrossRefGoogle Scholar
  4. 4.
    J. E. Fischer and R. H. Bower, Amino acid in liverdisease, in: “The Kidney in Liver Disease,” M. Epstein ed., Elsevier Publishing New York, 2nd edition, pp. 515–534 (1982).Google Scholar
  5. 5.
    F. E. Tristani and J. J. Cohn. Systemic and renal demodynamics in organic hepatic failure: Effect of volume expansion, J. Clin. Invest. 46: 1894 (1967).PubMedCrossRefGoogle Scholar
  6. 6.
    J. H. James, J. Escourrou,and J. E. Fischer, Blood brain neutral amino acid transport activity is increased after portacaval anastomosis, Science 200: 1395 (1978).Google Scholar
  7. 7.
    J. H. James, J. M. Hodgman, J. M. Funovics,and J. E. Fischer Alterations in brain octopamine and brain tyrosine following portacaval anastomosis in rats, J. Neurochem. 27: 223 (1967).Google Scholar
  8. 8.
    W. K. Oldendorf, Brain uptake of radiolabelled amino acids, amines and hexoses after arterial injection, Amer. J. Phys. 221: 1629 (1971).Google Scholar
  9. 9.
    B. A. Faraj, V. M. Camp, J. E. Ansley, J. Scott, F. M. Ali, and E. J. Malveaux, Evidence of central hypertyraminemia in hepatic encephalopathy, J. Clin. Invest. 67: 395 (1981).PubMedCrossRefGoogle Scholar
  10. 10.
    A. Nespoli, G. Bevilacqua, G. Staudacher, N. Rossi, E. Salerno, and M. R. Castelli, The role of false neurotransmitters in the pathogenesis of hepatic encephalopathy and hyperdinamic syndrome in cirrhosis, Arch. Surg. 116: 1129 (1981).Google Scholar
  11. 11.
    F. Rossi-Fanelli, F. H. Freund, R. Krause, A. R. Smith, J. H. James, S. Castorina-Ziparo,and J. E. Fischer, Induction of coma in normal dogs by infusion of aromatic amino acids and prevention by addition of branched chain amino acids, Gastroenterology 83: 664 (1982).PubMedGoogle Scholar
  12. 12.
    L. Zieve and R. L. Olsen, Can hepatic coma be caused by a reduction in brain noradrenaline or dopamine? Gut 18: 688 (1977).Google Scholar
  13. 13.
    W. T. Chance, A. P. Bernadini, J. H. James, L. L. Edwards, K.Minnema, and J.E. Fischer, Behavioral depression following intraventricular infusion of octopamine in rats. Submitted for publication.Google Scholar
  14. 14.
    J. H. James, V. Ziparo, B. Jeppson,and J. E. Fischer Hyperammonaemia, plasma amino acid imbalance, and blood-brain amino acid transport: A unified theory of portal systemic encephalopathy, Lancet ii: 772 (1979).Google Scholar
  15. 15.
    J. H. James and J. E. Fischer, The transport of neutral amino acids at the blood-brain barrier, Pharmacology 22: 1 ( 1980.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • J. E. Fischer
    • 1
  1. 1.Department of SurgeryUniversity of Cincinnati Medical CenterCincinnatiUSA

Personalised recommendations